Terms: = Prostate cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Clinical Outcome
1 results:
1. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG; Voss MJ; Zänker KS; Habashy HO; Green AR; Ellis IO; Entschladen F
Oncotarget; 2010 Nov; 1(7):628-38. PubMed ID: 21317458
[TBL] [Abstract] [Full Text] [Related]
